Elijah Stacy, Rare Disease Consultant

Elijah Stacy is an entrepreneur, author, and patient advocate dedicated to advancing genetic-based cures and biotechnology innovation. As a Board Member at DNA Nanobots, Elijah brings his expertise in patient advocacy, business development, and gene-editing technologies to help drive the company’s impact in precision medicine.

At just 15 years old, Elijah founded Destroy Duchenne, a 501(c)(3) nonprofit organization committed to accelerating gene-editing therapies—such as CRISPR—to treat Duchenne Muscular Dystrophy (DMD), a genetic disorder that has personally shaped his mission. His advocacy efforts have gained widespread recognition, including discussions with Amazon founder Jeff Bezos, and collaborations with leading biotech companies such as Capricor Therapeutics, Satellos Bioscience, and Solid Biosciences.